Step-Tip Chronic Hemodialysis Catheter
Arrow International
FDA Clearance Information
The step-tip chronic hemodialysis catheter was cleared by the FDA through the 510(k) pathway on May 14, 2004. It is manufactured by Arrow International and classified as a Class 2 medical device.
What It Is
FDA-Cleared Indications
- Use for vascular access in patients receiving chronic hemodialysis.
- Use when hemodialysis access is needed through a central vein.
- The catheter is an implanted hemodialysis catheter regulated under 21 CFR 876.5540, product code MSD.
Clinical Applications
- Long-term central venous access for hemodialysis.
- Hemodialysis in patients awaiting maturation of an arteriovenous fistula or graft.
- Hemodialysis when creation or use of an arteriovenous fistula or graft is not feasible.
- Repeated dialysis treatments through a tunneled catheter placed in a central vein.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Catheter length and configuration should match the access vein, exit site, patient anatomy, and prescribed dialysis blood-flow requirements.
- Placement is generally performed with ultrasound and fluoroscopic guidance, using local anesthesia with or without moderate sedation.
- Common central venous access sites include the internal jugular veins; femoral access may be used in selected circumstances. Subclavian access is often avoided when future arteriovenous access is possible.
- The catheter should be handled using strict sterile technique and locked according to the dialysis-unit protocol to reduce infection and thrombosis risk.
- MRI safety depends on the specific catheter model and its components. Confirm the current manufacturer labeling before MRI; do not assume that every chronic dialysis catheter is MR safe or MR conditional.
Frequently Asked Questions
What are the clinical indications for step-tip chronic hemodialysis catheter?
The catheter is indicated for providing long-term vascular access in patients undergoing hemodialysis, particularly when arteriovenous access is not possible.
What outcomes have been reported in clinical studies?
Studies have reported improved blood flow and reduced recirculation with step-tip catheters, though complications like thrombosis remain a concern.
What complications have been reported?
Safety data indicate complications such as thrombosis, fibrin sheath formation, and catheter-related infections.